Claudin-7 down-regulation is an important feature in oral squamous cell carcinoma

Histopathology

Volumn 57, Issue 5, 2010, Pages 689-698

  Lourenço, Silvia Vanessa ^a,b   Coutinho Camillo, Cláudia Malheiros ^c   Buim, Marcilei Elisa Cavicchioli ^c   De Carvalho, Ana Carolina ^d,e   Lessa, Roberta Cardim ^e   Pereira, Cláudia Maria ^e   Vettore, André Luiz ^d,e   Carvalho, André Lopes ^f   Fregnani, José Humberto ^f   Kowalski, Luiz Paulo ^c   Soares, Fernando Augusto ^a,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Institute of Tropical Medicine   (Brazil)

^c A C CAMARGO CANCER CENTER   (Brazil)

^d FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^e LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^f Hospital Do Cancer de Barretos   (Brazil)

Author keywords

Claudin 7; Oral cancer; Tight junction; Tissue microarray

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CLAUDIN 7; MESSENGER RNA;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METHYLATION; ORAL SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY;

PEREIRA;

EID: 78449274683     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03685.x     Document Type: Article

References (37)

1. Massano J, Regateiro FS, Januário G, Ferreira A. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2006; 102; 67-76.
2. Beenken SW, Urist MM. Head and neck tumors. In Way LN, Doherty GM eds. Current surgical diagnosis and treatmen, 11th edn. New York: Lange Medical Books/McGraw-Hill, 2003; 282-297.
3. Coleman JJ, Sultan MR. Tumors of the head and neck. In Schartz SI ed. Principles of surger, 7th edn. New York: McGraw-Hill, 1999; 601-665.
4. World Health Organization. The World Health Organization Report 2003. Geneva: World Health Organization, 2003; 6-7.
5. Woolgar JA. Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. Oral Oncol. 2006; 42; 229-239.
6. Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occluding. J. Cell Biol. 1998; 141; 1539-1550.
7. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat. Rev. Mol. Cell Biol. 2001; 2; 285-293.
8. Tsukita S, Furuse M. Occludin and claudins in tight-junction strands: leading or supporting players? Trends Cell Biol. 1999; 9; 268-273.
9. Furuse M, Sasaki H, Tsukita S. Manner of interaction of heterogenous claudin species within and between tight junction strands. J. Cell Biol. 1999; 147; 891-903.
10. Ivanov Ai, Nusrat A, Parkos CA. Endocytosis of epithelial apical junctional proteins by clathrin-mediated pathway into a unique storage compartment. Mol. Biol. Cell 2004; 15; 176-188.
11. De Oliveira SS, De Oliveira IM, De Souza W et al. Claudins upregulation in human colorectal cancer. FEBS Lett. 2005; 579; 6179-6185.
12. Resnick MB, Konkin T, Routhier J et al. Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod. Pathol. 2005; 18; 511-518.
13. Michl P, Buchholz M, Rolke M et al. Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology 2001; 121; 678-684.
14. Nichols LS, Ashfaq R, Iacobuzio-Donahue CA. Claudin-4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target. Am. J. Clin. Pathol. 2004; 121; 226-230.
15. Hoevel T, Macek R, Mundigl O et al. Expression and targeting of the tight junction protein CLDN1 in CLDN1-negative human breast tumor cells. J. Cell. Physiol. 2002; 191; 6-68.
16. Kominsky SL, Argani P, Korz D et al. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 2003; 22; 2021-2033.
17. Agarwal R, D'Souza T, Morin PJ. Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity. Cancer Res. 2005; 65; 7378-7385.
18. Rangel LB, Agarwal R, D'Souza T et al. Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin. Cancer Res. 2003; 9; 2567-2575.
19. Sheehan GM, Kallakury BVS, Sheenan CE, Fisher HAG, Kaufman RP, Ross JS. Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas. Hum. Pathol. 2007; 38; 564-569.
20. Krajewska M, Olson AH, Mercola D, Reed JC, Krajewski S. Claudin-1 immunohistochemistry for distinguishing malignant from benign epithelial lesions of prostate. Prostate 2007; 67; 907-910.
21. Al Moustafa AE, Alaoui-Jamali MA, Batist G et al. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 2002; 21; 2634-2640.
22. Usami Y, Chiba H, Nakayama F et al. Reduced expression of claudin-7 correlated with invasion and metastasis in squamous cell carcinoma of the esophagus. Hum. Pathol. 2006; 27; 569-577.
23. Lioni M, Brafford P, Andi C et al. Dysregulation of claudin-7 leads to loss of e-cadherin expression and the increased invasion of esophageal squamous cell carcinoma cells. Am. J. Pathol. 2007; 170; 709-721.
24. Bello IO, Vilen ST, Niinimaa A, Kantola S, Soini Y, Salo T. Expression of claudins 1, 4, 5, and 7 and occludin, and relationship with prognosis in squamous cell carcinoma of the tongue. Hum. Pathol. 2008; 39; 1212-1220.
25. Lourenço SV, Coutinho-Camillo CM, Buim ME, Uyekita SH, Soares FA. Human salivary gland branching morphogenesis: morphological localization of claudins and its parallel relation with developmental stages revealed by expression of cytoskeleton and secretion markers. Histochem. Cell Biol. 2007; 128; 361-369.
26. Chrigwin MJ, Przybyla EA, MacDonald R, Rutter J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18; 5294-5299.
27. Sauer T, Pedersen MK, Ebeltoft K, Naess O. Reduced expression of claudin-7 in fine needle aspirates from breast carcinomas correlate with grading and metastatic disease. Cytopathology 2005; 16; 193-198.
28. Fujibe M, Chiba H, Kojima T et al. Thr203 of claudin-1, a putative phosphorilation site for MAP kinase, is required to promote the barrier function of tight junctions. Exp. Cell Res. 2004; 295; 36-47.
29. Banan A, Zhang LJ, Shaikh M et al. Theta isoform of protein kinase C alters barrier function in intestinal epithelium through modulation of distinct claudin isotypes: a novel mechanism for regulation of permeability. J. Pharmacol. Exp. Ther. 2005; 313; 962-982.
30. D'Souza T, Agarwal R, Morin PJ. Phosphorylation of claudin-3 at threonine 192 by cAMP-dependent protein kinase regulates tight junction barrier function in ovarian cancer cells. J. Biol. Chem. 2005; 280; 26233-26240.
31. Yamauchi K, Rai T, Kobayashi K et al. Disease-causing mutant WNK4 increases paracellular chloride permeability and phosphorilates claudins. Proc. Natl Acad. Sci. USA 2004; 101; 4690-4694.
32. Tanaka M, Kamata R, Sakai R. EphA2 phosphorylates the cytoplasmic tail of claudin-4 and mediates paracellular permeability. J. Biol. Chem. 2005; 280; 42375-42382.
33. Oliveira SS, Morgado-Diaz JA. Claudins: multifunctional players in epithelial tight junctions and their role in cancer. Cell. Mol. Life Sci. 2007; 64; 17-28.
34. Esteller M, Corn PG, Baylin SB, Herman JG. A gene hypermethylation profile of human cancer. Cancer Res. 2001; 61; 225-3229.
35. Choi YD, Kim KS, Ryu S et al. Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma. J. Korean Med. Sci. 2007; 22; 305-310.
36. Roth MJ, Abnet CC, Hu N et al. p16, MGMT, RARbeta2, CLDN3, CRBP and MT1G gene methylation in esophageal squamous cell carcinoma and its precursor lesions. Oncol. Rep. 2006; 15; 1591-1597.
37. Boireau S, Buchert M, Samuel MS et al. DNA-methylation-dependent alterations of claudin-4 expression in human bladder carcinoma. Carcinogenesis 2007; 28; 246-258.